论文部分内容阅读
目的:探讨晚期乳腺癌患者诺维本联合阿霉素化疗的效果。方法:选择64例晚期和复发乳腺癌患者,对其用诺维本联合阿霉素静脉化疗的方法进行治疗,并对临床效果和不良反应进行观察分析。结果:完全缓解18例,部分缓解20例,稳定12例,进展16例;疾病控制率为78.13%,总有效率为59.38%;不良反应主要为粒细胞减少、贫血、恶心呕吐及脱发等。结论:对晚期乳腺癌患者行诺维本联合阿霉素化疗,疗效较好,不良反应相对较少,且患者依从性好。
Objective: To investigate the effect of Novolin combined with doxorubicin chemotherapy in patients with advanced breast cancer. Methods: Sixty - four patients with advanced and recurrent breast cancer were selected and treated with Novolin combined with doxorubicin intravenous chemotherapy. The clinical effects and adverse reactions were observed and analyzed. Results: The complete remission in 18 cases, partial remission in 20 cases, stable in 12 cases, progress in 16 cases; disease control rate was 78.13%, the total effective rate was 59.38%; adverse reactions were mainly neutropenia, anemia, nausea, vomiting and hair loss. Conclusion: The combination of nocitin and doxorubicin chemotherapy in patients with advanced breast cancer has better curative effect, fewer adverse reactions and good compliance.